Infinity Announces The Date Of Its Second Quarter 2018 Financial Results Conference Call And Webcast

July 31, 2018 at 4:05 PM EDT

CAMBRIDGE, Mass., July 31, 2018 /PRNewswire/ -- Infinity Pharmaceuticals, Inc. (NASDAQ: INFI) will host a conference call on Tuesday, August 7, 2018, at 4:30 p.m. ET to review its second quarter 2018 financial results and provide an update on the company.

A live webcast of the conference call can be accessed in the Investors/Media section of Infinity's website at www.infi.com. To participate in the conference call, please dial 1-877-316-5293 (domestic) or 1-631-291-4526 (international) five minutes prior to start time. The conference ID number is 8037589. An archived version of the webcast will be available on Infinity's website for 90 days.

About Infinity
Infinity is an innovative biopharmaceutical company dedicated to advancing novel cancer treatments. Infinity is advancing IPI-549, a potentially transformative immuno-oncology approach that aims to reprogram tumor-associated macrophages by selectively inhibiting PI3K-gamma. A Phase 1/1b study in approximately 200 patients with advanced solid tumors is ongoing. For more information on Infinity, please refer to Infinity's website at www.infi.com.

Contact:
Daniella Funaro, Stern Investor Relations, Inc.
212-362-1200 or daniella@sternir.com

Cision View original content:http://www.prnewswire.com/news-releases/infinity-announces-the-date-of-its-second-quarter-2018-financial-results-conference-call-and-webcast-300689428.html

SOURCE Infinity Pharmaceuticals, Inc.